Sihuan Pharma gets big response to HK IPO
Bankers working on an up-to HK$6.6bn ($852.3m) Hong Kong initial public offering for Sihuan Pharmaceutical Holding Group expect the deal to price at the top of the indicated price range on Wednesday.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts